Target
Induced myeloid leukemia cell differentiation protein Mcl-1
Ligand
BDBM520305
Substrate
n/a
Meas. Tech.
Fluorescence Polarization Competition Assay
Ki
57.0±n/a nM
Citation
 Zhuo, JLeal, RShetty, RLuengo, JCombs, APWei, P Spiro-sulfonamide derivatives as inhibitors of myeloid cell leukemia-1 (MCL-1) protein US Patent  US11130769 Publication Date 9/28/2021 
Target
Name:
Induced myeloid leukemia cell differentiation protein Mcl-1
Synonyms:
BCL2L3 | Bcl-2-like protein 3 | Bcl-2-like protein 3 (Mcl-1) | Bcl-2-related protein EAT/mcl1 | Bcl2-L-3 | Induced myeloid leukemia cell differentiation protein (Mcl-1) | MCL1 | MCL1_HUMAN | Mcl-1 | Myeloid Cell factor-1 (Mcl-1) | Myeloid cell leukemia sequence 1 (BCL2-related) | mcl1/EAT
Type:
Membrane; Single-pass membrane protein
Mol. Mass.:
37332.87
Organism:
Homo sapiens (Human)
Description:
Q07820
Residue:
350
Sequence:
MFGLKRNAVIGLNLYCGGAGLGAGSGGATRPGGRLLATEKEASARREIGGGEAGAVIGGSAGASPPSTLTPDSRRVARPPPIGAEVPDVTATPARLLFFAPTRRAAPLEEMEAPAADAIMSPEEELDGYEPEPLGKRPAVLPLLELVGESGNNTSTDGSLPSTPPPAEEEEDELYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEGGIRNVLLAFAGVAGVGAGLAYLIR
  
Inhibitor
Name:
BDBM520305
Synonyms:
US11130769, Ex. No. 22 | tert-Butyl 4-[2-[[6′-chloro-5-(cyclobutylmethyl)spiro[2,4-dihydro-1,5-benzoxazepine-3,1′-tetralin]-7-yl]sulfonylamino]-2-oxo-ethyl]piperidine-1-carboxylate
Type:
Small organic molecule
Emp. Form.:
C35H46ClN3O6S
Mol. Mass.:
672.274
SMILES:
CC(C)(C)OC(=O)N1CCC(CC(=O)NS(=O)(=O)c2ccc3OCC4(CCCc5cc(Cl)ccc45)CN(CC4CCC4)c3c2)CC1
Structure:
Search PDB for entries with ligand similarity: